Physician profile
Anna Rodis
NPI 1700534401
$1,683.10
in general payments reported to CMS, 2019-2025
15 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $253 · 2023: $505 · 2024: $564 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,429.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $405.55 | 2023-2025 | |
| Novo Nordisk INC | $335.18 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $193.04 | 2022-2024 | Breztri, Bevespi Aerosphere, Airsupra |
| Lilly USA, LLC | $173.76 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $170.29 | 2024-2025 | |
| Glaxosmithkline, LLC. | $108.15 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astellas Pharma US INC | $46.41 | 2023 | Veozah |
| Amgen INC. | $45.78 | 2025 | Krystexxa, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.63 | 2023-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.37 | 2022-2023 | Xifaxan |
| Actelion Pharmaceuticals US, INC. | $36.70 | 2024 | Opsumit, Uptravi |
| Exact Sciences Corporation | $23.94 | 2025 | Cologuard Collection Kit |
| Eisai INC. | $23.66 | 2025 | |
| Merck Sharp & Dohme LLC | $19.15 | 2023 | Vaxneuvance, M-M-R II, Rotateq |
| Kyowa Kirin, INC. | $17.49 | 2023 | Crysvita |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Rodis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.